16 Amendments of Frédérique RIES related to 2008/2208(INI)
Amendment 6 #
Motion for a resolution
Recital A a (new)
Recital A a (new)
Aa. Whereas nanomaterials are making a huge contribution to advances across a wide range of sectors; whereas these advances will ultimately be to the benefit of citizens and can make an important contribution to the competitiveness of the European Union’s economy; whereas these advances will also allow for improved policy decisions in the fields of public health, employment, occupational safety and health, information society, energy, transport, security and space,
Amendment 7 #
Motion for a resolution
Recital A a (new)
Recital A a (new)
Amendment 12 #
Motion for a resolution
Recital D
Recital D
D. whereas the current discussion about nanomaterials is characterised by many contradictions or even paradoxes, with disagreement and thus political struggles, starting at as basic a level as thwithin the European Union is characterised, like any conflicting debates on completely new technologies already present in daily life for which there is an element of the unknown as regards properties that may emerge, by the division of the scientific community into those in favour and those against research into nanotechnologies which has its corollary in political doctrine; whereas it would also be more definitions, for instance: − while nanomaterials are generally considered to be materials of a size in the order of 100 nm or lesfective to have these new technologies covered by a safe, multi-faceted and evolving body of law that would be based on a precautionary strategy to avoid the two pitfalls of systematic recourse to moratoria in the different properties due to size effects absence of full information on the should be an independent criterion for product or equivalent treatment for all the definition of nanomaterials, othis is often misrepresented as a range between 1 and 100 nm, even though the term “order” relaters products containing nanoparticles without suggest using this in a cumulative taking into account either their real harm manner, thus limiting the scope of the or the final use to which they are put, definition, while some people suggest to a dimension rather than to a precise size, – while many people believe that −hat the definition should be further narrowed to insoluble and persistent nanomaterials, thus already applying potential risk considerations at the level of definitions, others argue against such an a priori limitation,
Amendment 15 #
Motion for a resolution
Recital D b (new)
Recital D b (new)
Db. whereas the almost infinite application of nanotechnologies to such diverse sectors as electronics, textiles, biomedicals, health and well-being, agri- food or energy makes it impossible to introduce a single regulatory framework at Community level,
Amendment 17 #
Motion for a resolution
Recital E
Recital E
E. whereas in the context of REACH, it has so far not even been possible to agree on guidance on the identificationfurther guidance and advice ofn nanomaterials, leaving important decisions in the context of registration to economic operatorsin particular on substance identification, is needed,
Amendment 22 #
Motion for a resolution
Recital G
Recital G
G. whereas presentations about the potential benefits of nanotechnologies predict an almost infinite diversity of future applications of nanomaterials; however, the same diversity shrinks to near zero when it comes to a regulatory discussion about nanomaterial that need to be regulated if they are not already covered by present regulations,
Amendment 24 #
Motion for a resolution
Recital G a (new)
Recital G a (new)
Ga. whereas it is, at the same time, essential that the scope of existing Community legislation or Community legislation in the course of amendment be extended to cover nanomaterials. This includes Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market, Directive 2000/60/EC of the European Parliament and of the Council of 23 October 2000 establishing a framework for Community action in the field of water policy, Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients, Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives, Directive 2000/13/EC of the European Parliament and of the Council of 20 March 2000 on the approximation of the laws of the Member States relating to the labelling, presentation and advertising of foodstuffs, Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms, Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety, and Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products,
Amendment 49 #
Motion for a resolution
Recital M
Recital M
M. whereas a broad application of patents to nanomaterials, as well as the excessive cost of patenting and the absence of patent access facilities for very small businesses and small and medium-sized enterprises (SMEs), could stifle further innovation,
Amendment 54 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Is convinced that the benefits of nanomaterials can only be realised within a clear regulatory framework that fully addresses the very nature of potential safety problems relating to nawill be all the greater if they respond to the real needs of citizens, through the introduction of legislative or other standards that are tailored to the vast range of expected technological and industrial applications and pay heed to health and safety aspects as well as the research and development, protection of intellectual property rights and innomvaterialion dimensions;
Amendment 60 #
Motion for a resolution
Paragraph 4
Paragraph 4
4. Considers that as long as current legislation is devoid of any nano-specific provisions, and as long as data and even methods to assess the risks of nanomaterials are missing, better implementation of current law alone cannot bring about the necessary level of protection; it is important to include nanomaterials within the scope of Community legislation concerning everyday consumer products, and not just for legislation in the process of amendment such as Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products and Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients, but also Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market, Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives, Directive 2000/13/EC of the European Parliament and of the Council of 20 March 2000 on the approximation of the laws of the Member States relating to the labelling, presentation and advertising of foodstuffs, Regulation (EC) No 1830/2003 of the European Parliament and of the Council of 22 September 2003 concerning the traceability and labelling of genetically modified organisms and the traceability of food and feed products produced from genetically modified organisms, Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety, and Directive 2000/60/EC of the European Parliament and of the Council of 23 October 2000 establishing a framework for Community action in the field of water policy;
Amendment 65 #
Motion for a resolution
Paragraph 5
Paragraph 5
5. Considers that the proposed implementation focus does not provide the "safconcept of the "safe, responsible and integrated approach" to nanotechnologies advocated by the Commission, given that numerousEuropean Union, is jeopardized by the lack of information on nanomaterials that are already on the market, particularly in sensitive applications such as personal care products or cleaning products, without adequate safety assessment, and without adequate consumer information about these use. Asks the Commission to report before June 2011 on the presence and safety of nanomaterials on the European market and the extent of the need to create a Special European Fund, within the 7th Framework Programme, to finance research on the safe development and use of nanomaterials;
Amendment 71 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Calls on the Commission to propose reviews of all relevant legislation by the end of 2009 to fully implement the principle "no data, no market" for all applications of nanomaterials in consumer products or in products leadwith a probable or proven health or environmental impact used ing to discharges to the environmenthe preparation of consumer products;
Amendment 86 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Reiterates its call for labelling of consumer products containing nanomaterialsthe provision of information to consumers. All ingredients present in the form of nanomaterials shall be indicated in the list of ingredients by preceding the name of the ingredient with the word 'nano';
Amendment 89 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Calls for the urgent development of adequate testing protocols and metrology standards to assess the hazard of, and exposure to, nanomaterials over their entire life cycle, using a multi- disciplinary approach; and calls for the establishment of a Special European Fund, within the 7th Framework Program, to finance research on this field;
Amendment 101 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Calls for potentialRecognises that it is essential to remove the obstacles preventing very small businesses and SMEs in particular from accessing patents and calls at the same time for patent rights to be limited to specific applications or production methods of nanomaterials, and notonly to be extended to nanomaterials themselves on an exceptional basis, to avoid stifling innovation and to avoid creating a North- South "nano- divide";
Amendment 102 #
Motion for a resolution
Paragraph 11
Paragraph 11
11. Considers that stringent ethical guidelines need to be developed in due time to ensure full respect for ethical values in possible future use of nanotechnology converging with biomedical application, particularly for nanomedicine, such guidelines being the right to privacy, free and informed consent, the limits set on non-therapeutic human enhancement, whilst offering encouragement to this promising interdisciplinary domain with breakthrough technologies such as molecular imaging and diagnostics, which can offer impressive benefits for the early diagnosis and smart and cost-effective treatment of many diseases;